Amgen (AMGN) Announces Sumission of Kyprolis sNDA to FDA, MAA to EMA

January 27, 2015 4:35 PM

Amgen (NASDAQ: AMGN) and its subsidiary Onyx Pharmaceuticals, Inc., announced the submission of a supplemental New Drug Application (sNDA) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found